CLINICAL TRIALS PROFILE FOR ENDOMETRIN
✉ Email this page to a colleague
All Clinical Trials for ENDOMETRIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00296478 ↗ | Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF) | Completed | Ferring Pharmaceuticals | Phase 3 | 2005-07-01 | This multicenter, randomized, open-label study will be performed in approximately 990 healthy females undergoing IVF. Each study center will follow their study center standard practice for IVF unless otherwise noted in this protocol. The study centers will be provided with the medications for down regulation, stimulation and ovulation induction. The subjects will be randomized to study medication on the day of oocyte retrieval or the day following and will continue treatment for up to 10 weeks. The subjects with a confirmed pregnancy will be required to return to the clinic several times during the course of the 10 week treatment period for serum pregnancy tests and transvaginal ultrasounds to monitor the pregnancy. |
| NCT00345306 ↗ | Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan | Suspended | Hadassah Medical Organization | Phase 4 | 2007-03-01 | The transfer of frozen-thawed embryos can be performed in a natural ovulatory cycle or in a hormonally manipulated cycle with a comparable pregnancy rate of 15%-20% per ET. When a hormonally modulated ET cycle is scheduled,an artificial endometrial preparation is carried out using estrogen stimulation followed by a concomitant progesterone treatment. Two progestative drugs are currently used in conventional IVF treatment, Utrogetan and Endometrin. Although Endometrin has been be efficiently used to support the luteal phase after embryo transfer in IVF cycles, currently, there is no study that assess its efficacy for clinical use in frozen-thawed ET cycles. The present study aims to compare the outcome of frozen thawed ET cycles when either Endometrin or Utrogestan are used as the progestative substitution in an artificially prepared endometrium. |
| NCT00802360 ↗ | MENOPUR® Versus FOLLISTIM® | Completed | Ferring Pharmaceuticals | Phase 4 | 2008-12-01 | To compare the efficacy and safety of highly purified menotropin (Menopur®) with that of follitropin beta (FOLLISTIM®) in patients who are undergoing gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ENDOMETRIN
Condition Name
Clinical Trial Locations for ENDOMETRIN
Trials by Country
Clinical Trial Progress for ENDOMETRIN
Clinical Trial Phase
Clinical Trial Sponsors for ENDOMETRIN
Sponsor Name
| Sponsor Name for ENDOMETRIN | |
| Sponsor | Trials |
| Ferring Pharmaceuticals | 7 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| The George Washington University Biostatistics Center | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
